Recent Finacing
Recent Raise
AUM Biosciences is a clinical-stage oncology company developing in-house and collaborative small-molecule targeted therapies, advancing MNK and TRK inhibitors into Phase II alongside academic and pharmaceutical partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at AUM Biosciences.
